Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2017 by Nadine Tung, MD, Dana-Farber Cancer Institute
Sponsor:
Information provided by (Responsible Party):
Nadine Tung, MD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01670500
First received: August 16, 2012
Last updated: February 4, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2018
  Estimated Primary Completion Date: June 2018 (Final data collection date for primary outcome measure)